Please login to the form below
STEM
This page shows the latest STEM news and features for those working in and with pharma, biotech and healthcare.
Kite’s CAR-T therapies recommended by NICE for certain blood cancers
It can also be used with a stem cell transplant in some cases.
Latest news
-
bluebird bio submits US application for sickle cell gene therapy
gene into a patient’s own haematopoietic stem cells.
-
FDA approves Gamida’s cell therapy for blood cancer patients
Stem cell transplantation is a common treatment for blood cancers, which represent about 10% of annual US cancer cases. ... Each dose is patient-specific, containing healthy stem cells from a pre-screened donor.
-
Novo Nordisk and Aspect Biosystems partner in billion dollar deal for diabetes treatments
In a deal potentially worth up to 2.6bn, the collaboration will utilise Aspect’s proprietary bioprinting technology, as well as Novo's capabilities in stem cell differentiation and cell therapy
-
Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
B-ALL is the most common form of the disease in adult patients and, for those whose disease is refractory to or has relapsed following standard systemic therapy or haematopoietic stem
-
Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
dose chemotherapy and a stem cell transplant.
More from news
Approximately 20 fully matching, plus 455 partially matching documents found.
Latest Intelligence
-
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
In mantle cell lymphoma – where patients often require unpleasant stem cell transplantation procedures – TKI growth-blocker technology is increasing failure-free survival rates in younger patients.
-
ASH 2022: bad blood but big advances
CAR-T is offering an improvement on invasive stem cell therapy, manipulating cells to hunt down and kill cancer cells. ... Autologous stem cell transplantation (ASCT) is an aggressive procedure that some patients struggle to tolerate.
-
Paving the way for representation in clinical trials
workplace. Beyond Janssen, during my time as Chair of ABPI Wales 2019–2021, our DE&I focus included sponsoring the Womenspire Woman in STEM award and the work of Chwarae Teg,
-
The future of office working designed with our people in mind: ‘Work Where You Work Best’, an Evoke KYNE model
Our creativity and innovation stem from our people, so it’s critical that they continue to feel valued and included in a hybrid environment, that there is an understanding of their
-
Why female mentorship is so powerful in pharma
Who you know. Female mentorship has been proven to be effective in encouraging more young women to go into STEM fields.
More from intelligence
Approximately 1 fully matching, plus 67 partially matching documents found.
Latest appointments
-
Industry appointments
Rogerio Vivaldi leaves Bioverativ buyout to head up Sigilon. US-based biotech Sigilon aiming to deliver stem cell therapies for diabetes is getting a new leader.
-
Weekly industry appointments
There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory
-
Simon Doyle joins STEM
Benchmarking company STEM has appointed Simon Doyle as its new vice president of global customer relations and development. ... further drive value to STEM’s clients.
-
Storm Therapeutics bolsters its team
As a clinician-scientist at the University of Melbourne, Professor Dawson has experience in epigenetics having spent several years researching epigenetic regulation of leukaemia stem cells.
-
Porterhouse Medical promotes Emma Conran
Conran has served in medical writing positions at Porterhouse Medical since 2014 and prior to that she was a translational stem cell biology lecturer at King’s College London.
More from appointments
Approximately 3 fully matching, plus 17 partially matching documents found.
Latest from PMHub
-
Innovative HCP user experience earns award for Medthority platform
Part of the difficulty stems from poor digital maturity among pharma’s own medical education channels, with just a third of companies considering their digital HCP engagement to be ‘sophisticated’ or
-
#Wellbeing Week: Let's tackle pressure
Our solutions stem from four strategic workstreams: client servicing, training, leadership support, and wellbeing.
-
Webcast: From perceptions to prescribing: Combining forces with next-generation tracking and benchmarking to accelerate brand performance
In this webcast we demonstrate RP and STEM's integrated approaches which gives clients the level of insights they need to accelerate brand performance. ... We have the answer. Market research insights specialist Research Partnership and STEM joined
-
Serious about sustainability?
Though, I should point out Mathew and Caroline are not aware of this ambition of mine ;) ). Where do you think your passion for protecting the environment stems from?
-
How I’m helping to #BreakTheBias: International Women’s Day
Gender stereotypes and assumptions are rife and, as a child, the thought of working in STEM never crossed my mind.
More from PMHub
Approximately 3 fully matching, plus 39 partially matching documents found.
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Adaptive innovation
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
No results were found
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
